Interesting. According to this interview, Indonesia approached Recce for the trials/compounds. I expect this will mean no fluffing about, they're in need of a compound that works, and they'll be more than happy to streamline some major tests and research.
Also, considering the enormous and recent $40m Aus tax offset/rebate for overseas research, it quite clearly highlights that a large scale program may soon be underway.
[INTERVIEW] RCE teams with leading Indonesian biomed company for anti-infective push, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
39.5¢ |
Change
-0.025(5.95%) |
Mkt cap ! $114.2M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 42.0¢ | 39.0¢ | $53.51K | 130.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 571 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 1095 | 2 |
View Market Depth
| Last trade - 12.42pm 29/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |